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Abstract. 
 
It is not known how membrane fusion pro-
teins that function at neutral pH, for example the hu-
man immunodeficiency virus envelope (Env) glycopro-
tein and intracellular fusion machines, are activated for 
target bilayer binding. We have addressed this question 
using a soluble oligomeric form of an avian retroviral 
Env glycoprotein (API) and soluble forms of its recep-
tor. Binding of soluble receptor to API induces API to 
bind to liposomes composed of phosphatidylcholine 
and cholesterol at neutral pH. Liposome binding only 
occurs at fusion permissive temperatures (T 
 
. 
 
20
 
8
 
C), is 
complete between 2 to 5 min at 37
 
8
 
C, and is stable to 
high salt, carbonate, and urea. Liposome binding is me-
diated by the ectodomain of the transmembrane sub-
unit of API, and a mutant with a Val to Glu substitu-
tion in the Env fusion peptide (located in the 
ectodomain of the transmembrane subunit) shows sig-
nificantly reduced liposome binding. Moreover, under 
conditions of equivalent binding to API, a mutant re-
ceptor that does not support infection (Zingler, K., and 
 
J.A.T. Young. 1996. 
 
J. Virol.
 
 70:7510–7516) does not in-
duce significant liposome binding. Our results indicate 
that a highly specific interaction between an avian ret-
roviral Env and its receptor activates the retroviral gly-
coprotein for target bilayer binding at neutral pH in 
much the same way as low pH activates the influenza 
hemagglutinin. Our findings are discussed in terms of 
the mechanisms of viral and cellular fusion proteins 
that function at neutral pH.
P
 
rotein-mediated 
 
membrane fusion is a step in many
important biological processes (Rothman and War-
ren, 1994; Hernandez et al., 1996). Due to its rela-
tive simplicity, virus–cell fusion is an attractive system with
which to study the molecular basis of membrane fusion.
Fusion between an enveloped virus and a target cell is me-
diated by viral surface glycoproteins. For many viruses, fu-
sion takes place in the endosomal compartment where the
mildly acidic pH triggers structural rearrangements that
convert the fusion protein to a fusogenic form. The most
significant consequence of the low pH–induced conforma-
tional change is exposure of the fusion peptide and con-
comitant conversion of the previously hydrophilic ectodo-
main of the fusion protein to a hydrophobic form capable
of binding membranes.
Conversion to a hydrophobic form has been demon-
strated for the ectodomains of several low pH–dependent
viral fusion proteins including the hemagglutinin (HA)
 
1
 
 of
influenza virus and the E1 protein of Semliki Forest virus
(SFV; Harter et al., 1989; Bron et al., 1993; Klimjack et al.,
1994; White, 1995). A water-soluble ectodomain of the in-
fluenza HA (BHA) can be prepared by treating influenza
virus particles with bromelain. BHA aggregates if exposed
to low pH in aqueous solution (Skehel et al., 1982). If,
however, target membranes are present during the low pH
treatment, BHA associates with membranes (Skehel et
al., 1982; Doms et al., 1985). Photolabeling experiments
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1. 
 
Abbreviations used in this paper
 
: ALSV, avian leukosis and sarcoma vi-
rus; API, GPI-linked ALSV subgroup A Env glycoprotein; BHA, brome-
lain-released hemagglutinin; DAF, decay-accelerating factor; DTT,
dithiothreitol; ECL, enhanced chemiluminescence; Env, envelope glyco-
protein; GPI, glycosylphosphatidylinositol; HA, hemagglutinin; HIV, human
immunodeficiency virus; LDL, low density lipoprotein; NSF, N-ethylma-
leimide-sensitive factor; PI-PLC, phosphatidylinositol-specific phospholi-
pase-C; RT, room temperature; SFV, Semliki Forest virus; sTva, soluble
ALSV subgroup A receptor; SU, surface; TM, transmembrane; Tva,
ALSV subgroup A receptor; wt, wild-type.
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have shown that this interaction is mediated by the fusion
peptide (Harter et al., 1989). In addition, a mutant HA
with a Gly to Glu substitution at position 1 of the fusion
peptide, which displays no fusion activity, shows reduced
(
 
z
 
50%) liposome binding (Gething et al., 1986). The E1
ectodomain of SFV also binds to target membranes when
exposed to low pH (Klimjack et al., 1994), and mutations
in the SFV fusion peptide that impair fusion also affect li-
posome binding (Kielian et al., 1996).
Many viruses do not require low pH in order to fuse with
host cells, and appear to be able to fuse directly at the
plasma membrane. This includes members of approxi-
mately half of the known families of enveloped viruses
including serious pathogens such as the human immunode-
ficiency virus (HIV) and respiratory syncytial virus (Her-
nandez et al., 1996). In contrast to what is known about the
mechanisms of viral fusion proteins that function at low
pH, little is known about the mechanisms of viral fusion
proteins that function at neutral pH. Unlike viruses that
fuse at low pH, those that fuse at neutral pH appear to re-
quire host cell receptors or additional factors (Weiss, 1992).
Because of this we and others have proposed that interac-
tion of the neutral pH viral fusion protein with its host cell
receptor(s) triggers conformational changes in the viral fu-
sion protein that activate it for fusion (White, 1990; Weiss,
1992). By analogy to the low pH–induced activation of the
influenza HA and the SFV E1, the transition to a fuso-
genic state would include exposure of the previously bur-
ied fusion peptide whose interaction with the target mem-
brane would initiate fusion. As far as we know, all cellular
fusion reactions such as trafficking of endocytic and exo-
cytic vesicles, egg fertilization, and myotube formation
occur at neutral pH. Therefore cellular membrane fusion
proteins/machines may use similar receptor-mediated strat-
egies to initiate fusion.
A number of receptors for enveloped viruses that fuse at
neutral pH have now been identified (Weiss, 1992; Bro-
jatsch et al., 1996; Deng et al., 1996; Feng et al., 1996).
Studies with the HIV envelope glycoprotein (Env) and its
primary receptor, CD4, have provided preliminary sup-
port for the basic theory of “receptor-induced” activation.
Upon binding to CD4, HIV Env undergoes a number of
conformational changes, including exposure of the V3
loop as well as changes in sensitivity to proteolysis and an-
tibody binding (Sattentau et al., 1993; Matthews et al.,
1994; Stamatatos and Cheng-Mayer, 1995; Sullivan et al.,
1995). In addition, structural data suggest that there may
be similarities between fusion-related forms of the influ-
enza HA (Bullough et al., 1994) and HIV Env (Chan et al.,
1997; Weissenhorn et al., 1997). Attainment of the former
structure does (White and Wilson, 1987; Bullough et al.,
1995) and attainment of the latter structure most likely in-
volves large conformational changes. Despite these noted
changes, neither exposure of the fusion peptide nor
changes in hydrophobicity have yet been demonstrated for
HIV Env upon binding of either CD4 or a chemokine re-
ceptor, two host cell factors required for HIV entry.
Like most retroviruses, the avian leukosis and sarcoma
virus (ALSV) fuses at neutral pH (Gilbert et al., 1990). Its
Env is synthesized as an inactive precursor that is cleaved
intracellularly by a host protease into a surface (SU) and a
transmembrane (TM) subunit. The SU and TM subunits re-
main associated with each other through a disulfide
bond(s) and form a trimer of SU/TM heterodimers (Ein-
feld and Hunter, 1988). The SU subunit has determinants
for receptor binding whereas the TM subunit anchors the
protein in the viral membrane and contains the fusion pep-
tide. For most retroviruses the fusion peptide is located at
the NH
 
2
 
 terminus of the TM protein, but ALSV is unique
among known retroviruses in that its fusion peptide is in-
ternal to the NH
 
2
 
 terminus of the TM subunit (Hernandez,
L.D., and J.M. White, manuscript submitted for publica-
tion). Structural models suggest a strong similarity be-
tween the ALSV TM and the Ebola virus glycoprotein im-
plying that aspects of their fusion mechanisms may be
similar (Gallaher, 1996).
Differing host range, receptor binding, and interference
patterns have divided ALSV into five major subgroups
designated A–E. The host cell receptor for ALSV-A is a
small transmembrane protein termed Tva (Bates et al.,
1993; Young et al., 1993); Tva binds specifically to the sub-
group A envelope glycoprotein (Connolly et al., 1994; Gil-
bert et al., 1994). The extracellular domain of Tva has a
single copy of a cysteine-rich motif, seven of which are
present in the low density lipoprotein (LDL) receptor.
This 40–amino acid repeat motif is sufficient to mediate vi-
rus entry (Rong and Bates, 1995). We have previously
shown that upon interaction with sTva, a soluble form of
the Tva ectodomain, Env A undergoes a temperature-
dependent conformational change in the SU subunit that
correlates with the activation of its fusion function (Gil-
bert et al., 1995). Here we show that binding of Tva at fu-
sion-permissive temperatures renders the Env A ecto-
domain hydrophobic as measured by a liposome binding
assay. Liposome binding is mediated by the TM subunit
and, at least in part, by the fusion peptide. Liposome binding
also appears to require a specific sequence in the receptor.
This is the first example of receptor-induced conversion of
the ectodomain of a fusion protein that functions at neu-
tral pH from a hydrophilic to a hydrophobic entity.
 
Materials and Methods
 
Construction of API-Glu2
 
The KpnI-AflII fragment from pCB6-Env-API (GPI-linked Env A; Gil-
bert et al., 1993) was replaced with the corresponding KpnI-AflII frag-
ment of pCB6-Glu2 yielding pCB6-Glu2-PI. The resulting Env gene has
the single amino acid substitution Val to Glu at residue 30 of the TM sub-
unit (in the fusion peptide) as well as the signal for glycosylphosphatidyli-
nositol (GPI) addition in place of the transmembrane domain and cyto-
plasmic tail.
 
Tissue Culture
 
The pCB6-Glu2-PI plasmid was transfected into NIH 3T3 cells by the cal-
cium phosphate precipitation method (Wigler et al., 1977). 24 h after
transfection, cells were placed in selective medium (DME, 10% supple-
mented calf serum; [Hyclone, Logan, UT], and 500 mg/Liter geneticin
GIBCO BRL, Gaithersburg, MD) for 14 d. Geneticin-resistant clones were
picked and screened for expression of envelope protein after treatment
for 16–18 h with 10 mM sodium butyrate (Sigma Chemical Co., St. Louis,
MO), and the highest expressing clones were amplified. The NIH 3T3 cell
line expressing Env-API was maintained in the above medium and has
been described previously (Gilbert et al., 1993). Env-API cells were
treated for 16–18 h with 5 mM sodium butyrate to induce higher Env-API
expression levels. The secreted form of Tva (sTva) was a gift of P. Bates
(University of Pennsylvania, Philadelphia, PA)
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Antibodies and Reagents
 
The anti-Tva antiserum used was that described previously (Bates et al.,
1993) and was a gift of P. Bates (University of PA, Philadelphia, PA). Poly-
clonal antisera were raised in rabbits against peptides corresponding to
part of the host range 2 (hr2) domain of the SU subunit of Env A (amino
acids 206–220), and the decay-accelerating factor glycosylphosphatidyl-
inositol (DAF-GPI) signal peptide. These latter antibodies were affinity
purified by chromatography over their respective peptides coupled to Sul-
foLink resin (Pierce, Rockford, IL) according to the manufacturer’s in-
structions. Phosphatidylinositol-specific phospholipase-C (PI-PLC) was
purified from an overexpressing bacterial strain (Koke et al., 1991). A gift
of P. Bjorkman (California Institute of Technology, Pasadena, CA) and
O. Griffith Hayes (University of Oregon, Eugene, OR). Two additional
soluble forms of Tva, s47 and s47WA, were purified and refolded from
overexpressing bacterial strains.
 
Biotinylation and Coimmunoprecipitation
Binding Assay
 
After induction with sodium butyrate (5 mM for API and 10 mM for
Glu2-PI) for 16–18 h, cells expressing GPI-anchored proteins were labeled
with the membrane-impermeant reagent NHS-LC-biotin (Pierce) and
treated with PI-PLC as described previously (Gilbert et al., 1993). sTva,
s47, and s47WA proteins were biotinylated on ice for 45 min in PBS (pH
7.8) containing 0.5 mM MgCl
 
2
 
 and 1 mg/ml NHS-LC-biotin. The excess bi-
otin was quenched by the addition of 50 mM glycine for 1–18 h at 4
 
8
 
C. For
coimmunoprecipitation of s47 and API, the indicated amount of biotiny-
lated s47 or s47WA protein was incubated with unlabeled PI-PLC–
released API for 1 h on ice in a total volume of 200 
 
m
 
l. Anti-DAF anti-
body was added and incubated for 1 h at 4
 
8
 
C followed by another 1-h incu-
bation after the addition of protein A–agarose (Boehringer Mannheim
Biochemicals, Indianapolis, IN). Samples were washed four times in lysis
buffer (Hepes-buffered saline with 1% Nonidet P-40), boiled, and re-
duced in Laemmli sample buffer, and separated by SDS-PAGE. Proteins
were transferred to nitrocellulose and probed with streptavidin coupled to
HRP (strep-HRP; Pierce) to detect biotinylated proteins. The HRP signal
was detected by enhanced chemiluminescence (ECL; Amersham Corp.,
Arlington Heights, IL).
For measuring sTva dissociation from API, unlabeled PI-PLC–released
API was immunoprecipitated with anti-DAF/protein A–agarose as de-
scribed above. Samples were washed four times in calcium- and magne-
sium-free PBS (PBS
 
22
 
). Biotinylated sTvA was added to the immunopre-
cipitates on ice for 20 min. Liposomes or PBS
 
22
 
 was added and samples
were incubated for 5 min at 37
 
8
 
C. An additional 100 
 
m
 
l PBS
 
22
 
 was added
and the samples were centrifuged at 14,000 rpm in a microcentrifuge for
10 s at 4
 
8
 
C. Supernatants were chloroform–methanol precipitated as de-
scribed below. The immunecomplexes and the supernatant proteins were
analyzed by SDS-PAGE and blotted with strep-HRP.
 
Liposome Binding Assay
 
Liposomes were freshly prepared before each experiment as described
previously (White and Helenius, 1980) and contained phosphatidylcholine
and cholesterol (Sigma Chemical Co.) in a 4:1 molar ratio. Biotinylated PI-
PLC released GPI-linked envelope glycoproteins were incubated with sol-
uble receptor (either sTva, s47, or s47WA) or diluted fetal calf serum on
ice for 15 min in a total volume of 60 
 
m
 
l. PI-PLC released material from
 
z
 
2 
 
3
 
 10
 
6
 
 cells was used for each sample. 40 
 
m
 
l of liposomes were then
added and the samples were incubated at the indicated temperature for
the indicated amount of time. 300 
 
m
 
l of 67% sucrose was added to bring
the final concentration of sucrose to 50%. This solution was overlaid with
300 
 
m
 
l of 25% sucrose and 200 
 
m
 
l of 10% sucrose in a clear polycarbonate
ultracentrifuge tube (Beckman Instruments Inc., Fullerton, CA). After
centrifugation at 200,000 
 
g
 
 for 3 h at 4
 
8
 
C, 9 
 
3
 
 100 
 
m
 
l fractions were col-
lected from the top of the gradient, brought up to a final volume of 400 
 
m
 
l
with lysis buffer, immunoprecipitated with the anti-DAF antibody, sepa-
rated by SDS-12.5% PAGE and processed for the detection of biotiny-
lated proteins as described above. For quantitation of liposome binding,
blots were probed with 
 
125
 
I-labeled streptavidin, dried, and exposed to a
phosphorimaging screen. Exposed phosphorimaging screens were scanned
into a PhosphorImager workstation using the ImageQuant program (Mo-
lecular Dynamics, Inc., Sunnyvale, CA). Protein band intensities were de-
termined by summing the pixels in a constant volume rectangle. The top
three fractions are defined as liposome bound. For 6 M urea, 1 M NaCl,
and 15 mM carbonate (pH 11.0) treatments, liposomes with bound API
were incubated with the appropriate solution for 10 min at room temperature
(RT) before the addition of the sucrose solution. For the detection of sTva,
fractions were chloroform-methanol precipitated: 10 
 
m
 
l of salmon sperm
DNA (1 mg/ml) was added to each 100 
 
m
 
l fraction. 550 
 
m
 
l methanol, 150 
 
m
 
l
chloroform, and 550 
 
m
 
l H
 
2
 
O were added. Samples were vortexed and cen-
trifuged at 14,000 rpm in a microcentrifuge for 3–5 min at RT. The top layer
was aspirated and 550 
 
m
 
l of methanol was added to the bottom layer. Sam-
ples were again vortexed and centrifuged at 14,000 rpm in a microcentri-
fuge. Pellets were resuspended in Laemmli sample buffer, boiled, and then
processed by SDS-PAGE and Western blotting with the anti-Tva antibody.
 
Dissociation of the SU and TM Subunits
 
Biotinylated PI-PLC–released API was incubated with or without s47 on
ice as described above. Liposomes were added and the mixture was incu-
bated for 5 min at 37
 
8
 
C. 75 
 
m
 
l of 8 M urea and 17.5 
 
m
 
l of 1 M DL-dithio-
threitol (DTT) were then added and the solution was incubated at RT for
an additional 20 min before being placed in the bottom of a sucrose step
gradient and processed as described above. Fractions were immunopre-
cipitated with either anti-DAF or a mixture of both the anti-DAF and
anti-hr2 antibodies.
 
Results
 
sTva Induces API Liposome Binding
 
Exposure of influenza HA or SFV E1 to acidic conditions
triggers the conversion of each ectodomain to a hydropho-
bic form capable of binding to liposomes (Skehel et al.,
1982; Doms et al., 1985; Gething et al., 1986; Harter et al.,
1989; Klimjack et al., 1994). We performed a liposome bind-
ing assay using the water-soluble Env A ectodomain, API,
to test whether binding of sTva to Env A causes an analo-
gous change in the hydrophobicity of the Env A ectodo-
main. API is a GPI anchored form of Env A that contains
the signal for GPI addition from DAF in place of the Env
A transmembrane and cytoplasmic tail domains. It is ex-
pressed, oligomerized, and transported to the cell surface
in a manner similar to full-length Env A. It can be removed
from the cell surface with PI-PLC yielding a water-soluble
oligomer (Gilbert et al., 1993). The soluble oligomer binds
specifically to the subgroup A receptor (Gilbert et al., 1994),
and undergoes a temperature-dependent conformational
change in the SU subunit upon this interaction in a manner
similar to full-length Env A (Gilbert, 1995; Hernandez,
L.D., unpublished results). In this paper, the term API refers
to the PI-PLC–released soluble oligomeric form of API.
For the first liposome binding assays, biotinylated API
was incubated with sTva on ice to allow formation of the
sTva–API complex (Gilbert et al., 1994). After 15 min, li-
posomes composed of phosphatidylcholine and choles-
terol were added and the samples were incubated at 37
 
8
 
C
for 30 min, returned to 4
 
8
 
C, placed in the bottom of a cen-
trifuge tube, overlaid with a sucrose step gradient, and
subjected to ultracentrifugation. The gradient was frac-
tionated and the position of API was determined by im-
munoprecipitation with an anti-DAF antibody that recog-
nizes the first nine residues at the COOH terminus of the
engineered TM subunit. In the absence of sTva, API did
not bind liposomes and remained at the bottom of the gra-
dient (Fig. 1, 
 
top
 
). In the presence of sTva, however, API
was found at the top of the gradient indicating it had asso-
ciated with the liposomes (Fig. 1, 
 
bottom
 
).
Because Tva is related to the LDL receptor (Bates et al.,
1993), it was possible that sTva itself has an affinity for li-
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posomes. We therefore asked which component of the
sTva–API complex is responsible for liposome binding. sTva
alone or the sTva–API complex was incubated with lipo-
somes at 37
 
8
 
C for 30 min and analyzed for liposome bind-
ing by a sucrose flotation gradient as described above.
Fractions were chloroform–methanol precipitated and West-
ern blotted with anti-Tva serum. sTva that had not been
incubated with API remained at the bottom of the gradi-
ent showing that sTva itself does not have strong affinity
for liposomes (Fig. 2 
 
A
 
, 
 
top
 
). sTva that had been prebound
to API and incubated with liposomes also remained at the
bottom of the gradient (Fig. 2 
 
A
 
, 
 
bottom
 
) indicating that it
had dissociated from API, which floats to the top of the
gradient (Fig. 1). We used a more sensitive method for de-
tecting receptor by using biotinylated sTva in the liposome
binding assay and determining where it ran in the gradient.
Again sTva was found only at the bottom of the gradient
(data not shown). This was somewhat unexpected since
sTva binds to Env A with a 
 
K
 
d
 
 of 1.5 nM (Zingler and
Young, 1996; Rong et al., 1997) and remains bound to Env
A through sucrose density centrifugation and coimmuno-
precipitation in detergent-containing solutions (Gilbert et
al., 1994). As shown in Fig. 2 
 
B
 
 by a coimmunoprecipita-
tion assay, a significant fraction of sTva dissociates from
API in the presence, but not in the absence, of liposomes.
sTva contains the entire 83–amino acid extracellular do-
main of Tva. Within this domain the 40–amino acid LDL
receptor repeat binding motif suffices to mediate virus en-
try (Rong and Bates, 1995). We therefore generated in 
 
Es-
cherichia coli
 
 and refolded a 47–amino acid fragment of
Tva that contains the 40-residue LDL receptor repeat mo-
tif (Peters, R., and D. Agard, unpublished results). s47
binds to Env A and induces the same structural changes in
Env A that sTva does (Hernandez, L., and J.M. White, un-
published results). Since we found s47 to be a more stable
reagent than sTva, we used s47 as the “receptor” for all
subsequent experiments.
 
Stability of Liposome Binding
 
We examined the stability of the receptor-induced API–
liposome interaction by treating API–liposome complexes
with 6 M urea, high salt (1 M sodium chloride) or carbon-
ate, pH 11.0 ,before centrifugation. As seen in Fig. 3, none
of these treatments affected the attachment of API to lipo-
somes. The interaction of API with liposomes is therefore
nonionic, hydrophobic, and stable.
 
Time and Temperature Dependence of
Liposome Binding
 
We next examined the time course of liposome binding by
Figure 1. Receptor-induced liposome binding. Biotinylated PI-
PLC–released API was incubated with or without sTva for 15 min
at 48C incubated with liposomes at 378C for 30 min and then ana-
lyzed on flotation gradients as described in Materials and Meth-
ods. Gradients were fractionated, and samples were immunopre-
cipitated with anti-DAF antibody, boiled and reduced, separated
by SDS-12.5% PAGE, transferred to nitrocellulose, probed with
streptavidin-HRP, and visualized by ECL to identify API.
Figure 2. sTva dissociates from API. (A) sTva or sTva-API was
incubated with liposomes and subjected to centrifugation as in
Fig. 1. Gradient fractions were chloroform-methanol precipi-
tated, separated by SDS-12.5% PAGE, transferred to nitrocellu-
lose, and Western blotted with anti-Tva serum. (B) Unlabeled
API was immunoprecipitated with the anti-DAF antibody and
protein A agarose. Biotinylated sTva was added to the immuno-
precipitates on ice for 20 min. Liposomes or PBS were added and
samples were incubated for 5 min at 378C. Beads were centri-
fuged and the supernatants collected and chloroform-methanol
precipitated. Beads and supernatant proteins were reduced,
boiled, separated by SDS-12.5% PAGE, transferred to nitrocel-
lulose, and blotted with streptavidin-HRP.
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varying the length of the 37
 
8
 
C incubation with liposomes
from 1 to 30 min. Samples were subjected to sucrose flota-
tion gradients and analyzed as described above. API bind-
ing to liposomes occurs rapidly and is complete between 2
to 5 min at 37
 
8
 
C (Fig. 4, 
 
A
 
 and 
 
B
 
). This is similar to BHA
which binds to liposomes within 1 to 2 min after exposure to
low pH (Doms et al., 1985; Gething et al., 1986).
ALSV binds to chicken embryo fibroblasts at 4
 
8
 
C but
only fuses with them at temperatures 
 
.
 
22
 
8
 
C (Gilbert et al.,
1990). We therefore proposed that activation of the ALSV
fusion protein must be temperature-dependent. Our previ-
ous studies on Tva–Env interactions are consistent with
this hypothesis; sTva causes a change in the sensitivity of
the SU subunit of Env A to thermolysin at 37
 
8
 
C but not at
4
 
8
 
C (Gilbert et al., 1995). We therefore asked if receptor-
induced liposome binding is temperature-dependent. To
do this API–s47 complexes were incubated with liposomes
for 5 min at 4
 
8
 
, 10
 
8
 
, 22
 
8
 
, or 37
 
8
 
C, returned to 4
 
8
 
C, and ana-
lyzed for liposome binding (Fig. 5). Little liposome bind-
ing was detected at 4
 
8
 
 or 10
 
8
 
C. Liposome binding then in-
creased as the temperature was further increased with a
high degree of binding (72%) occurring at 37
 
8
 
C. These re-
sults show that liposome binding is temperature-depen-
dent similar to the sTva-induced conformational change in
SU and ALSV fusion with chicken embryo fibroblast cells.
 
TM Subunit Binds Liposomes
 
We next asked which subunit of API (SU or TM) mediates
liposome binding. SU and TM are associated through a
disulfide bond(s). We found that they could be dissociated
but only by treatment with 100 mM DTT and 6 M urea.
Under these conditions the anti-DAF antibody efficiently
immunoprecipitates TM and an antibody against the hr2
region of Env efficiently immunoprecipitates SU (Fig. 6
 
A
 
). It is interesting that the anti-hr2 antibody only recog-
nized SU after treatment with urea/DTT, suggesting that
the hr2 epitope is obstructed or in a different conforma-
tion in native API. Similar results were obtained with full
length Env A (Delos, S., and J. White, unpublished re-
sults).
Biotinylated API bound to receptor (s47) was incubated
with liposomes for 5 min at 37
 
8
 
C. The sample was then
treated with urea and DTT for 20 min at room tempera-
ture, and analyzed by a flotation gradient. Gradient frac-
tions were immunoprecipitated with either anti-DAF (Fig.
6 
 
B
 
, 
 
top
 
) or a combination of anti-DAF and anti-hr2 an-
Figure 3. Stability of the API–liposome interaction. API–lipo-
some complexes were incubated with either 1 M NaCl, 6 M urea,
or 15 mM carbonate, pH 11.0, for 10 min at RT. Samples were
processed as described in the legend to Fig. 1.
Figure 4. Time course of liposome
binding. The API–s47 complex was
incubated with liposomes at 378C
for varying amounts of time and an-
alyzed on sucrose flotation gradi-
ents. (A) Sucrose gradient fractions
were immunoprecipitated and pro-
cessed as in Fig. 1. (B) Sucrose gra-
dient fractions were immunoprecip-
itated and processed as in Fig. 1
with the exception that the blots
were probed with 125I-labeled
streptavidin and subjected to quan-
titation by phosphorimager analysis
as described in Materials and Meth-
ods. (% Bound) The percent API in
the top three fractions.
Figure 5. Temperature dependence of liposome binding. The
API–s47 complex was incubated with liposomes for 5 min at the
indicated temperatures and analyzed on sucrose flotation gradi-
ents. Sucrose gradient fractions were immunoprecipitated, pro-
cessed, and quantitated as described in the legend to Fig. 4 B.
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tibodies (Fig. 6 
 
B
 
, 
 
bottom
 
). Immunoprecipitation with
anti-DAF (Fig. 6 
 
B
 
, 
 
top
 
) showed that TM and SU are effi-
ciently dissociated from each other by the urea/DTT treat-
ment; only TM was detected in the immunoprecipitates.
Despite this, with s47-pretreated API the majority of TM
remained bound to the liposomes (migrated to the top of
the gradient). The TM subunit is more spread out in the
gradient (Fig. 6 
 
B
 
) than in samples that had not been
treated with urea/DTT (e.g., Fig. 1). This is likely due to
the combined action of urea and DTT, since treatment
with urea alone did not cause TM to spread out on the gra-
dient (Fig. 3, middle). When samples of the API–liposome
complexes were incubated with urea/DTT, SU stayed at
the bottom of the gradient (Fig. 6 B, bottom). Conversely
TM from the same sample migrated to the top of the gra-
dient (Fig. 6 B, bottom). These results show that TM, and
not SU, mediates API binding to liposomes.
Liposome Binding Properties of a Fusion
Peptide Mutant
Studies with the influenza HA have demonstrated that li-
posome binding (at low pH) is mediated by the fusion pep-
tide (Harter et al., 1989). We therefore hypothesized that
the ALSV fusion peptide mediates liposome binding. We
have recently shown that mutations in the candidate fu-
sion peptide of ALSV Env A (residues 21–42 of TM) sig-
nificantly impair the ability of Env A to mediate both virus–
cell and cell–cell fusion without affecting Env processing,
folding, oligomerization, cell surface expression, receptor
binding, or ability to undergo a receptor-induced confor-
mational change (Hernandez, L.D., and J.M. White, man-
uscript submitted for publication). We therefore constructed
a GPI-linked form of one of these mutants (Val30Glu)
and tested it in the liposome binding assay. The GPI form
of this mutant is referred to as Glu2-PI. Glu2-PI was im-
paired in receptor-induced liposome binding (Fig. 7 A,
middle) when compared to wt API (Fig. 7 A, bottom). The
Glu2-PI protein was spread out in the gradient suggesting
that its interaction with liposomes was relatively weak.
Quantitation of the data indicated that Glu2-PI binds to li-
posomes with z50% the efficiency of wt API (Fig. 7 B).
This phenotype is similar to the behavior of the Gly1 to Glu
HA fusion peptide mutant (Gething et al., 1986). These re-
sults support our hypothesis that the fusion peptide medi-
ates liposome binding (see Discussion).
Mutant Tva Does Not Induce Significant
Liposome Binding
Residues 46–48 in the Tva ectodomain are crucial for virus
entry (Zingler et al., 1995; Zingler and Young, 1996). A
substitution that replaced the tryptophan at position 48
with alanine reduced infectivity titers approximately three
to four orders of magnitude, but only decreased cell sur-
face Tva binding affinity for an ALSV–A SU–Ig fusion
protein approximately sevenfold (Zingler and Young, 1996).
These findings suggested that the W48A mutant has a de-
fect in a postbinding step(s) necessary for virus entry. We
therefore asked if W48A could induce liposome binding.
s47WA, a soluble form of the W48A Tva mutant analo-
gous to s47, was expressed in E. coli, purified, and refolded
(Peters, R., and D. Agard, unpublished results). By our
coimmunoprecipitation assay, s47WA appeared to bind to
API approximately 100-fold less well than wild-type (wt)
s47 (Fig. 8 A). This apparent 100-fold reduction in binding
Figure 6. API binds liposomes through the TM subunit. (A) Biotinylated API was incubated with either PBS, 6 M urea, or 6 M urea/100
mM DTT for 20 min at RT in a total volume of 100 ml. Samples were brought up to 400 ml with PBS and immunoprecipitated with anti-
DAF or anti-hr2 antibody and processed as described in the legend to Fig. 1. (B) The s47-induced API–liposome complex was treated
with 6 M urea and 100 mM DTT before centrifugation to dissociate the TM and SU subunits. Each sucrose gradient fraction was immu-
noprecipitated with anti-DAF or a mixture of anti-DAF and anti-SU antibodies and processed as described in the legend to Fig. 1.
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differs from the sevenfold reduction reported by Zingler
and Young (1996), and may be due to differences in the
systems used. Nonetheless equal binding to API could be
achieved using 100 times more s47WA protein than wt s47
(Fig. 8 A). Under conditions of comparable binding, the
s47WA receptor (1003) did not induce significant lipo-
some binding when compared to (13) wt s47 (Fig. 8 B).
With 1003 mutant receptor the majority of TM stays at
the bottom of the gradient. If the amount of mutant recep-
tor is further increased (2503) to binding levels that ex-
ceed the wt (Fig. 8 A), API now appears to spread on the
gradient. Nonetheless, even using 2503 mutant protein,
API does not display a clear cut liposome binding pheno-
type as occurs with 13 of the wt receptor (Fig. 8 B).
Discussion
In this study we present the first evidence that receptor
binding to a neutral pH fusion protein transforms its
ectodomain into a hydrophobic entity capable of binding
to target membranes. Moreover, we show that soluble
forms of the receptor are fully competent to elicit this re-
sponse. This is the first demonstration of its kind for any
fusion protein that functions at neutral pH. After interac-
Figure 7. Liposome binding capability of Glu2-PI. The position 2
glutamate mutant protein (Glu2-PI) was assayed for liposome
binding as in Fig. 4. Fractions were immunoprecipitated with
anti-DAF, processed by SDS-12.5% PAGE and transferred to ni-
trocellulose. Blots were probed with (A) streptavidin-HRP (visu-
alized by enhanced chemiluminescence), or (B) 125I-labeled strep-
tavidin (quantitated by phosphorimager analysis as described in
Materials and Methods). (% Bound) Percent API or Glu2-PI in
the top three fractions.
Figure 8. Ability of a mutant receptor, s47WA, to (A) bind to
API and (B) induce liposome binding. (A) Indicated amounts of
biotinylated s47 or s47WA protein were incubated with equal
amounts of PI-PLC–released API protein in a total volume of
200 ml for 1 h on ice. Samples were immunoprecipitated with the
anti-DAF antibody, separated by SDS-15% PAGE and trans-
ferred to nitrocellulose. Blots were probed with streptavidin-HRP
and visualized by enhanced chemiluminescence. 13 5 0.36 mg
protein. (B) Biotinylated PI-PLC–released API was incubated
with 0.36 mg (13) s47 or 3.6 mg (103), 36 mg (1003), or 90 mg
(2503) s47WA protein at 48C for 20 min. Liposomes were added
and samples were incubated at 378C for 5 min before centrifuga-
tion. Fractions were analyzed as described in the legend to Fig. 1.
Similar results were obtained with the s47WA mutant (1003)
when the 48C incubation step was increased to 90 min.
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tion with soluble receptor, the ALSV Env A ectodomain
binds to liposomes composed solely of phosphatidylcho-
line and cholesterol. Binding is stable and nonionic in na-
ture, temperature dependent (T . 208C), and it is com-
plete between 2 to 5 min at 378C. Somewhat surprisingly,
the Env A-receptor complex appears to dissociate after
Env A binds to liposomes. Liposome binding is mediated
by the TM subunit of Env A and, at least in part, by the fu-
sion peptide; a mutant in the fusion peptide region is sig-
nificantly impaired in its ability to bind to liposomes. Fur-
thermore, a mutant receptor that is competent to bind Env
A but is unable to support virus infection (Zingler and
Young, 1996) is compromised in its ability to induce lipo-
some binding. We propose that this receptor-induced
change in hydrophobicity of a neutral pH fusion protein
ectodomain is analogous to the low pH–induced activation
of fusion proteins such as the influenza HA (Doms et al.,
1985; Gething et al., 1986) and the SFV E1 protein (Klim-
jack et al., 1994).
HA, the most extensively characterized viral fusion pro-
tein, is a homotrimer composed of two disulfide bonded sub-
units: HA1, which confers receptor binding activity, and
HA2 which contains the fusion peptide. When exposed to
low pH, the previously buried fusion peptide of HA2 is re-
vealed and repositioned to interact with membranes, and
the HA1 globular head domains separate from each other
and from HA2 (White and Wilson, 1987; Bullough et al.,
1994; Hernandez, 1996). Along with our previous findings,
the results presented here suggest that ALSV Env A may
undergo similar changes during fusion activation.
As for HA, a drastic change in the hydrophobicity of the
ALSV-A ectodomain occurs in response to a trigger. In
the case of HA the trigger is low pH; in the case of Env A
the trigger is a temperature-dependent sequence-specific
interaction with the viral receptor, Tva. Because Tva is suf-
ficient to induce a change in the hydrophobicity of Env A,
it appears highly likely that Tva is the only host factor re-
quired for fusion. This differs from HIV, which needs at least
two receptors, CD4 and a chemokine receptor, to mediate
virus entry (reviewed in Bates, 1996). Whereas CD4 bind-
ing has been shown to induce some structural changes in
HIV Env, interaction of HIV Env with a chemokine re-
ceptor may be necessary to induce changes that expose the
HIV fusion peptide and transforms its ectodomain into a
hydrophobic form. Because soluble forms of Tva are able
to induce Env A binding to liposomes, it is clear that, at
least in the ALSV system, the proteinaceous fusion trigger
does not need to be embedded in the target membrane to
elicit the first steps of the fusion process. In this respect, it
will be interesting to see if soluble Tva can induce virus–
liposome fusion.
Previous studies suggested that Trp-48 of Tva may be an
important determinant for triggering postbinding events
necessary for fusion (Zingler et al., 1995; Zingler and Young,
1996). Our results are consistent with this prediction; the
W48A Tva mutant, s47WA, is impaired in its ability to in-
duce liposome binding even under conditions in which its
binding to the Env A ectodomain is comparable to or ex-
ceeds that of wt Tva. Our results therefore show that bind-
ing of Tva to Env is necessary, but not sufficient, to effect
a change in the hydrophobicity of the Env ectodomain; the
two proteins must interact in a highly specific and temper-
ature-dependent manner in order to induce the structural
changes necessary for target bilayer binding. Trp-48 ap-
pears to be an important contact point in this interaction.
In response to its trigger, low pH, the fusion peptide of
HA is exposed and the ectodomain becomes hydrophobic.
Here we have clearly shown that in response to its trig-
ger—specific Tva binding—the Env A ectodomain becomes
hydrophobic. We propose that the increase in hydropho-
bicity is due at least in part to exposure of the fusion pep-
tide. In previous work we have shown that an antibody
against the Env A fusion peptide reacts preferentially with
Env A following binding to Tva at T . 228C (Gilbert et al.,
1995). Here we show that a mutant in the Env A fusion
peptide (Val30 to Glu) that is abolished in fusion activity
(Hernandez, L.D., and J.M. White, manuscript submitted
for publication) is significantly compromised in its ability
to bind to liposomes: binding of the Glu-substituted mu-
tant to liposomes was z50% and appeared unstable com-
pared to that of the wt Env ectodomain. We believe that
the phenotype of Glu-substituted mutant is caused by the
presence of a charged residue, glutamate, in the hydropho-
bic surface of the Env A fusion peptide. In this respect the
phenotype of the Glu-substituted Env is highly reminis-
cent of the first fusion peptide mutant: Gly1fi Glu of the
HA fusion peptide (Gething et al., 1986). This original HA
fusion peptide mutant binds to liposomes less well (z50%)
than wt HA (see Fig. 8 in Gething et al., 1986). Future
studies using techniques such as labeling with photoacti-
vatable phospholipids (Harter et al., 1989; Durrer et al.,
1995) are necessary to test whether the hydrophobic inter-
action between the Env A ectodomain and target bilayers
is an exclusive property of the fusion peptide. Computer
modeling has predicted that the Ebola virus glycoprotein
is structurally very similar to the ALSV TM subunit (Gal-
laher, 1996) with an analogous region postulated to act as
the fusion peptide. Our results suggest that the corre-
sponding region in the Ebola glycoprotein may act in a
similar manner to attach the fusion protein to target mem-
branes under fusion-inducing conditions.
In the case of HA, exposure to low pH also causes the
globular head domains (HA1) to separate from each other,
and this dissociation is necessary for fusion (Godley et al.,
1992; Kemble et al., 1992). We have observed two struc-
tural changes in the receptor binding subunit (SU) of Env
in response to its fusion trigger: SU becomes sensitive to
thermolysin (Gilbert et al., 1995) and it dissociates from
sTva in the presence of liposomes (Fig. 2). Analogous to
HA, the structural changes in the Env SU subunit may re-
flect separation of the receptor binding domains of Env
and they may be necessary for fusion.
Recently, CAR1 has been identified as the receptor for
members of two cytopathic subgroups of ALSV, ALSV-B
and ALSV-D (Brojatsch et al., 1996). CAR1 is a member
of the tumor necrosis factor receptor family and contains
two extracellular cysteine-rich domains and a death do-
main in its cytoplasmic tail that has been implicated in vi-
rus-induced cell death. CAR1 is not related to Tva or to
any other known retroviral receptor. It will now be possi-
ble to determine if different ALSV subgroups, cytopathic
and noncytopathic, share a common mechanism for activa-
tion of their fusion proteins despite using highly unrelated
receptors. For example, it will be interesting to determine
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if CAR1 binding to Env B or D induces analogous struc-
tural changes to those seen in Env A upon Tva binding,
particularly conversion of the Env B or D ectodomain to a
hydrophobic entity.
While relatively little is known about viral fusion proteins
that function at neutral pH, even less is known about en-
dogenous proteins that mediate cell–cell fusion and intra-
cellular fusion events, all of which are thought to occur at
neutral pH. Several candidate cell–cell fusion proteins
have been identified, including fertilin (Blobel et al., 1992)
and meltrin (Yagami-Hiromasa et al., 1995), members of
the ADAM gene family (Wolfsberg and White, 1996) in-
volved in sperm–egg and myoblast fusion, respectively.
N-ethylmaleimide–sensitive factor (NSF), soluble NSF-
attachment proteins, and soluble NSF-attachment proteins
receptors, are involved in intracellular fusion reactions such
as vesicular transport between Golgi compartments (for
reviews see Rothman and Warren, 1994; Denesvre and
Malhotra, 1996; Monck and Fernandez, 1996). The large
number of proteins involved in cell–cell and intracellular
fusion events suggests that these latter fusion events are
more complex than the apparent two component ALSV
system. Nonetheless, the overall general fusion mecha-
nism may be similar: specific protein–protein interactions
cause conformational changes that expose a hydrophobic
region(s) in one or more of the members of the fusion pro-
tein complex. This conformational change would, in turn,
enable the fusion protein(s) to bind hydrophobically to
target membranes and initiate membrane merger (Her-
nandez et al., 1996). In view of the findings presented here,
it is now reasonable to consider, for example in the case of
intracellular fusion events (Rothman and Warren, 1994;
Denesvre and Malhotra, 1996; Monck and Fernandez,
1996), that a soluble protein may act as the fusion trigger.
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